Hi. Consider whether annual revenues upon which royalties are...

Hi. Consider whether annual revenues upon which royalties are based in your model could be increased two, three or four fold. An earlier posting on this message board had median annual pricing for drugs of this sort to be $200k per annum (while your model is based on the Nuplazid per annum result which is significantly less). Also in my opinion the linear curve uptake should differ and be better than the Nuplazid linear curve because the community for Rhetts is a tightly knit community compared to the looser affiliation, if any, of folks with Parkinson’s Disease Psychosis. All of the above in my opinion.